Pharmacotherapeutics in Critical Care is a first-of-its-kind, comprehensive drug compilation built specifically for the pharmacological complexity of critical illness. The interplay of multiple organ dysfunctions, extracorporeal support, unique critical-illness pathophysiology, and multi-drug regimens makes drug selection in the ICU genuinely difficult — this 728-page reference distills that complexity into a crisp, standardized, drug-by-drug template covering 20 chapters of intensive care pharmacotherapy. Every drug is presented in the same standard format for fast, consistent lookup, with a dedicated special section on ECMO and other extracorporeal therapies and a particular emphasis throughout on Pk-Pd (pharmacokinetic-pharmacodynamic) behaviour — the exact information an intensivist needs to adjust dosing safely in the critically ill. Who This Book Is For: Practicing Intensivists: a fast, standardized drug reference built for decision-making at the bedside, including at odd hours. Critical Care Fellows and Residents: a structured way to learn ICU pharmacotherapy beyond what general pharmacology textbooks cover. Anesthesiologists and OT Practitioners: drug guidance relevant to perioperative and critical-care crossover scenarios. Why This Book Helps: Simplifies a genuinely complex decision: untangles multi-organ dysfunction, extracorporeal support, and drug interactions into one consistent format. Saves time under pressure: a crisp, standardized template designed for quick lookup by an intensivist working at odd hours. Covers a critical, often-underserved area: a dedicated section on drug management during ECMO and extracorporeal therapies. Improves dosing safety: consistent emphasis on Pk-Pd behaviour throughout, not just standard dosing tables. Key Features: First-of-its-kind compilation of critical care pharmacotherapeutics, 728 pages across 20 chapters Crisp, standardized template applied consistently to every drug Dedicated special section on ECMO and extracorporeal therapies Special emphasis on Pk-Pd (pharmacokinetic-pharmacodynamic) behaviour Produced under the Hyderabad Intensive Care Symposium (HICS) editorial team